|
000
| 01804cam 2200385zi 4500 |
|---|
| 001 | 9.870384 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107163113 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 190321t20192019xxc #ob f000 0 eng d |
|---|
| 020 | |a9780660301969 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-313/2019E-PDF |
|---|
| 245 | 00|aGuidance document : |bPart C, division 5 of the Food and Drug Regulations “Drugs for clinical trials involving human subjects”. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2019. |
|---|
| 264 | 4|c©2019 |
|---|
| 300 | |a1 online resource (99 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Document d'orientation : Titre 5 de la partie C du Règlement sur les aliments et drogues « Drogues destinées aux essais cliniques sur des sujets humains ». |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"GUI-0100." |
|---|
| 500 | |a"August 20, 2019." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references (pages 95-99). |
|---|
| 692 | 07|2gccst|aDrug laws |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 775 | 08|tDocument d'orientation : |w(CaOODSP)9.870386 |
|---|
| 776 | 0#|tPart C, division 5 of the food and drug regulations “Drugs for clinical trials involving human subjects”.|w(CaOODSP)9.870385 |
|---|
| 856 | 40|qPDF|s794 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H14-313-2019-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-clinical-practices/guidance-documents/guidance-drugs-clinical-trials-human-subjects-gui-0100.html |
|---|